Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical formulations containing dopamine receptor ligands

Pharmaceutical formulations containing dopamine receptor ligands

US Patent RE49302 · Granted Nov 15, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical formulations containing dopamine receptor ligands2022
Pharmaceutical formulations containing dopamine receptor ligands2022
Pharmaceutical formulations containing dopamine receptor ligands2022
Stable formulations of linaclotide2020
Stable formulations of linaclotide2020
Modified release formulations of memantine oral dosage forms2020
Micronized colistimethane sodium pharmaceutical compositions2019
Pharmaceutical formulations containing dopamine receptor ligands2019
Pharmaceutical formulations containing dopamine receptor ligands2019
Pharmaceutical formulations containing dopamine receptor ligands2019
Pharmaceutical formulations containing dopamine receptor ligands2019
Pharmaceutical formulations containing dopamine receptor ligands2019